p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer

Cited by (227)

Items 101–200 of 227

  1. Nestin contributes to skeletal muscle homeostasis and regeneration
    Julia Lindqvist, Elin Torvaldson, Josef Gullmets, Henok Karvonen, András Nagy, Pekka Taimen, John Eriksson · 2017 · Journal of Cell Science
  2. Molecular Dynamics Simulation-assisted Ionic Liquid Screening for Deep Coverage Proteome Analysis
    Fei Fang, Qun Zhao, Huiying Chu, Mingwei Liu, Baofeng Zhao, Zhen Liang, Lihua Zhang, Guohui Li, Liming Wang, Jun Qin et al. · 2020 · Molecular & Cellular Proteomics
  3. Titration of RAS alters senescent state and influences tumour initiation
    Adelyne Sue Li Chan, Haoran Zhu, Masako Narita, Liam D. Cassidy, Andrew R. J. Young, Camino Bermejo‐Rodríguez, Aleksandra T. Janowska, Hung‐Chang Chen, Sarah Gough, Naoki Oshimori et al. · 2024 · Nature
  4. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR
    Mengying Wu, Jiahui An, Qidi Zheng, Xiaoru Xin, Zhuojia Lin, Xiaonan Li, Haiyan Li, Dongdong Lu · 2016 · Oncotarget
  5. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications
    Aroosha Raja, Farhan Ul Haq · 2021 · Journal of Cancer Research and Clinical Oncology
  6. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network
    Tami J. Kingsbury, Min-Jung Kim, Curt I. Civin · 2019 · Advances in cancer research
  7. p53 balances between tissue hierarchy and anarchy
    Gabriela Koifman, Ronit Aloni-Grinstein, Varda Rotter · 2019 · Journal of Molecular Cell Biology
  8. Lineage tracing: technology tool for exploring the development, regeneration, and disease of the digestive system
    Yue Zhang, Fanhong Zeng, Xu Han, Jun Weng, Yi Gao · 2020 · Stem Cell Research & Therapy
  9. Distribution, contribution and regulation of nestin+ cells
    Ziyang Tong, Zi Yin · 2023 · Journal of Advanced Research
  10. Identification of β-Amino alcohol grafted 1,4,5 trisubstituted 1,2,3-triazoles as potent antimalarial agents
    N. Devender, Sarika Gunjan, Stuti Chhabra, Kartikey Singh, Venkata Reddy Pasam, Sanjeev K. Shukla, Abhisheak Sharma, Swati Jaiswal, Sunil Kumar Singh, Yogesh Kumar et al. · 2015 · European Journal of Medicinal Chemistry
  11. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy
    Hye‐Lim Ju, Kwang‐Hyub Han, Jong Doo Lee, Simon Weonsang Ro · 2015 · International Journal of Cancer
  12. p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer
    Xin Yuan Sui, Jianye Cai, Hongyu Li, Chenchen He, Congya Zhou, Yiping Dong, Li Chen, Bin Zhang, Yingnan Wang, Yanan Zhang et al. · 2018 · Cell Death and Disease
  13. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
    Kayla Guidry, Varshini Vasudevaraja, Kristen E. Labbe, Hussein Mohamed, Jonathan Serrano, Brett W. Guidry, Michael DeLorenzo, Hua Zhang, Jiehui Deng, Soumyadip Sahu et al. · 2022 · Clinical Cancer Research
  14. Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach
    Lei Chen, Tao Huang, Yuhang Zhang, Yang Jiang, Mingyue Zheng, Yu‐Dong Cai · 2016 · Scientific Reports
  15. Nestin Is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells
    Qinglin Wang, Hao Wu, Jian Hu, Haijuan Fu, Yanghui Qu, Yijun Yang, Kathy Qi Cai, Andrey Efimov, Minghua Wu, Tim J. Yen et al. · 2021 · Molecular Cancer Research
  16. Unraveling cancer lineage drivers in squamous cell carcinomas
    Yinglu Guan, Guan Wang, Danielle M Fails, Priyadharsini Nagarajan, Yejing Ge · 2019 · Pharmacology & Therapeutics
  17. A chaotic outlook on biological systems
    Yael Scharf · 2016 · Chaos Solitons & Fractals
  18. p53-Dependent Repression: DREAM or Reality?
    Sylvain Peuget, Galina Selivanova · 2021 · Cancers
  19. Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate‐cell carcinoma?
    Deborah Malvi, Dario de Biase, Silvia Fittipaldi, Marco Grillini, Michela Visani, Annalisa Pession, Antonia D'Errico, Francesco Vasuri · 2019 · Histopathology
  20. Nestin Expression as a Diagnostic and Prognostic Marker in Colorectal Cancer and Other Tumors
    Anna Szymańska–Chabowska, Filip Świątkowski, Beata Jankowska‐Polańska, Grzegorz J. Mazur, Mariusz Chabowski · 2021 · Clinical Medicine Insights Oncology
  21. Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
    Liping Zhong, Yong Huang, Jian Guo He, Nuo Yang, Banghao Xu, Yun Ma, Junjie Liu, Chao Tang, Cheng‐Piao Luo, Pan Wu et al. · 2021 · Signal Transduction and Targeted Therapy
  22. Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
    April Andrews, Kristy A. Warner, Christie Rodriguez-Ramirez, Alexander T. Pearson, Felipe Nör, Zhaocheng Zhang, Samuel A. Kerk, Aditi Kulkarni, Joseph I. Helman, John Chad Brenner et al. · 2018 · Clinical Cancer Research
  23. Nestin-Expressing Cells in the Lung: The Bad and the Good Parts
    Jaramillo-Rangel, Gilberto, Chávez-Briones, María-de-Lourdes, Ancer-Arellano, Adriana, Ortega-Martínez, Marta · 2021 · Cells
  24. MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
    Yadira M. Soto‐Feliciano, Changyu Zhu, John P. Morris, Chun‐Hao Huang, Richard P. Koche, Yu-Jui Ho, Ana Banito, Chun-Wei David Chen, Aditya Shroff, Sha Tian et al. · 2023 · eLife
  25. p53 in liver pathologies—taking the good with the bad
    Meital Charni‐Natan, Noa Rivlin, Alina Molchadsky, Ronit Aloni-Grinstein, Varda Rotter · 2014 · Journal of Molecular Medicine
  26. Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma
    Chengzhi Xie, Guoxing Liu, Min Li, Fang Yu, Ke Qian, Yu Tang, Xiaolong Wu, Xiaohua Lei, Xiaocheng Li, Qiang Liu et al. · 2019 · Biomedicine & Pharmacotherapy
  27. YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte‐Like Cells
    Jordan L. Smith, Tomás Rodríguez, Haiwei Mou, Suet‐Yan Kwan, Henry Pratt, Xiao‐Ou Zhang, Yueying Cao, Shun‐Qing Liang, Deniz Mahmut Özata, Tianxiong Yu et al. · 2020 · Hepatology
  28. Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination
    Tomasz Gromowski, Veronika Lukacs‐Kornek, Jarosław Cisowski · 2023 · Cancer Cell International
  29. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification
    Zhongqi Fan, Meishan Jin, Lei Zhang, Nanya Wang, Mingyue Li, Chuanlei Wang, Wei Qi Feng, Ping Zhang, Xiaohong Du, Xiaodong Sun et al. · 2023 · Gut
  30. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells
    Claire Barbieux, Jalal Bacharouche, Charles Soussen, Sébastien Hupont, Angélina Razafitianamaharavo, Remi V. Klotz, Rémi Pannequin, David Brie, Philippe Bécuwe, Grégory Francius et al. · 2016 · Nanoscale
  31. PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells
    Carolin Seifert, Ellen Balz, Susann Herzog, Anna Korolev, Sebastian Gaßmann, Heiko Paland, Matthias A. Fink, Markus Grube, Sascha Marx, Gabriele Jedlitschky et al. · 2021 · International Journal of Molecular Sciences
  32. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma
    Sungjin Ko, Minwook Kim, Laura Maria Molina, Alphonse Eugene Sirica, Satdarshan P. Monga · 2022 · Advances in cancer research
  33. Miat and interacting protein Metadherin maintain a stem-like niche to promote medulloblastoma tumorigenesis and treatment resistance
    Kai-Lin Peng, Harish N. Vasudevan, Dennis Timothy Lockney, Rachel Baum, Ronald C. Hendrickson, David Ronan Raleigh, Adam M. Schmitt · 2022 · Proceedings of the National Academy of Sciences
  34. Transcriptional repression of IKKβ by p53 in arsenite-induced GADD45α accumulation and apoptosis
    Yongliang Hu, Rui Jin, Ming Gao, Huan Xu, Shuxian Zou, Xiaoguang Li, Xing Chen, Qiyu Wang, Hongli Wang, Jiannan Feng et al. · 2018 · Oncogene
  35. Is nestin a diagnostic marker for combined hepatocellular–cholangiocarcinoma?
    Motoko Sasaki, Y Sato, Yasuni Nakanuma · 2022 · Histopathology
  36. Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis
    Lim, Bryce, Kamal, Aryan, Gomez Ramos, Borja, Adrian Segarra, Juan M., Ibarra, Ignacio L., Dignas, Lennart, Kindinger, Tim, Volz, Kai, Rahbari, Mohammad, Rahbari, Nuh et al. · 2025 · Nature Genetics
  37. Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
    Mayra A. Marques, Guilherme Caldas de Andrade, Jerson Lima Silva, Guilherme A. P. de Oliveira · 2022 · Frontiers in Molecular Biosciences
  38. Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension
    Aneel Roy Bhagwani, Schuyler Hultman, Daniela Farkas, Rebecca K. Moncayo, Kaivalya Dandamudi, Arsema K Zadu, Carlyne D. Cool, László Farkas · 2019 · PLoS ONE
  39. Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU via TCF21/CD44 Axis-Mediated Enhanced Stemness in Colorectal Carcinoma
    Xiaolei Gao, Xuan Zheng, Yixin Zhang, Liying Dong, Liangjie Sun, Na Zhao, Chong Ding, Zeyun Ma, Yixiang Wang · 2022 · Frontiers in Cell and Developmental Biology
  40. p53 functional loss, stemness and hepatocellular carcinoma
    Claude Caron de Fromentel, Massimo Levrero · 2020 · Hepatoma Research
  41. Nestin is essential for cellular redox homeostasis and gastric cancer metastasis through the mediation of the Keap1–Nrf2 axis
    Jing Lv, Meiqiang Xie, Shufen Zhao, Wensheng Qiu, Shasha Wang, Manming Cao · 2021 · Cancer Cell International
  42. p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett’s oesophagus
    Guodong Lian, Ermanno Malagola, Chengguo Wei, Qiongyu Shi, Junfei Zhao, Masahiro Hata, Hiroki Kobayashi, Yosuke Ochiai, Biyun Zheng, Xiaofei Zhi et al. · 2024 · Gut
  43. Comparing stemness gene expression between stem cell subpopulations from peripheral blood and adipose tissue.
    María Teresa González‐Garza, Delia E. Cruz‐Vega, Alejandro Cárdenas-Lopez, Rosa Maria de la Rosa, Jorge Eugenio Moreno-Cuevas · 2018 · Europe PMC (PubMed Central)
  44. RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence
    Joseph L. Regan, Dirk Schumacher, Stephanie Staudte, Andreas Steffen, Ralf Lesche, Joern Toedling, Thibaud Jourdan, Johannes Haybaeck, Dominik Mumberg, David Andrew Henderson et al. · 2021 · iScience
  45. Involvement of Felis catus papillomavirus type 2 in the tumorigenesis of feline Merkel cell carcinoma
    Soma Ito, James Kenn CHAMBERS, Ayumi Sumi, Nanako Yamashita‐Kawanishi, Tetsuo Omachi, Takeshi Haga, Hiroyuki Nakayama, Kazuyuki Uchida · 2021 · Veterinary Pathology
  46. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
    Ludovica Ceci, Tianhao Zhou, Ilaria Lenci, Vik Meadows, Lindsey Leann Kennedy, Ping Li, Burcin Ekser, Martina Milana, Wenjun Zhang, Chaodong Wu et al. · 2022 · Cancers
  47. The chameleonic behavior of p53 in health and disease: the transition from a client to an aberrant condensate scaffold in cancer
    Mayra A. Marques, Guilherme A. P. de Oliveira, Jerson Lima Silva · 2022 · Essays in Biochemistry
  48. TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation
    Evin İşcan, Umut Ekin, Gökhan Yıldız, Özden Öz, Umur Keles, Aslı Süner, Gulcin Cakan‐Akdogan, Günes Özhan, Marta Nekulová, Bořivoj Vojtěšek et al. · 2021 · Cancers
  49. Biliary tract cancer stem cells - translational options and challenges
    Christian Mayr, Matthias Ocker, Markus Ritter, Martin Pichler, Daniel Neureiter, Tobias Kiesslich · 2017 · World Journal of Gastroenterology
  50. Detection of Marker-Free Precision Genome Editing and Genetic Variation through the Capture of Genomic Signatures
    Pierre Billon, Tarun S. Nambiar, Samuel B. Hayward, María Paz Zafra, Emma M. Schatoff, Koichi Oshima, Andrew Jeffrey Dunbar, Marco Breinig, Young C. Park, Han-Seul Ryu et al. · 2020 · Cell Reports
  51. Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships
    Marco Breinig, Artem Lomakin, Elyas Heidari, Michael A. Ritter, Gleb D. Rukhovich, Lio Böse, Luise Butthof, Lena Wendler-Link, Hendrik Wiethoff, Tanja Poth et al. · 2025 · Nature Biomedical Engineering
  52. Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives
    Hoda A. Elkhenany, Ahmed Shekshek, Mohamed M. Abdel‐Daim, Nagwa El‐Badri · 2019 · Advances in experimental medicine and biology
  53. Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
    Peeranate Vanaroj, Wanna Chai่jaroenkul, Kesara Na‐Bangchang · 2023 · Asian Pacific Journal of Cancer Prevention
  54. Studying Nestin and its Interrelationship with Cdk5
    Julia Lindqvist, Num Wistbacka, John Eriksson · 2015 · Methods in enzymology on CD-ROM/Methods in enzymology
  55. Hippo signaling and epithelial cell plasticity in mammalian liver development, homeostasis, injury and disease
    Randy L. Johnson · 2019 · Science China Life Sciences
  56. Cellular Origin of Hepatocellular Carcinoma
    Doris Schneller, Peter E. Angel · 2019 · Codon Publications eBooks
  57. Deciphering Antitumor Mechanism of Pien Tze Huang in Mice of Hepatocellular Carcinoma Based on Proteomics
    Dancai Fan, Chang Liu, Li Li, Cheng Chang Lu, Ning Zhao, Jun Shu, Xiaojuan He, Aiping Lü · 2020 · Journal of Immunology Research
  58. The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance
    Priya Mondal, Syed Musthapa Meeran · 2023 · Cancer and Metastasis Reviews
  59. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)
    Peeranate Vanaroj, Wanna Chai่jaroenkul, Kesara Na‐Bangchang · 2022 · Molecular and Clinical Oncology
  60. A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets
    Xiang Li, Chun‐Hao Huang, Francisco J. Sánchez Rivera, Margaret C. Kennedy, Darjus Felix Tschaharganeh, John P. Morris, Antonella Montinaro, Kevin P. O’Rourke, Ana Banito, John Erby Wilkinson et al. · 2022 · Proceedings of the National Academy of Sciences
  61. Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
    Jose Reyes, Isabella S. Del Priore, Andrea C. Chaikovsky, Nikhita Pasnuri, Ahmed M. Elhossiny, Jin Park, Philipp Weiler, Tobias Krause, Andrew R Moorman, Catherine Snopkowski et al. · 2026 · Cell
  62. Glycine Promotes the Survival of a Subpopulation of Neural Stem Cells
    Abdelhamid Bekri, Pierre Drapeau · 2018 · Frontiers in Cell and Developmental Biology
  63. Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study
    Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  64. YTHDF3-mediated m6A modification of NKD1 regulates hepatocellular carcinoma invasion and metastasis by activating the WNT/β-catenin signaling axis
    Siyan Chen, Lumin Wang, Zhenguo Xu, Lushan Chen, Quansen Li, Fengjin Zhong, Nanhong Tang, Jun Song, Ruixiang Zhou · 2024 · Experimental Cell Research
  65. Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
    Oihane Erice, Adrián Vallejo, Mariano Ponz‐Sarvisé, Michael Saborowski, Arndt Vogel, Diego Francesco Calvisi, Anna Lena Saborowski, Silvestre Vicent · 2019 · Cancers
  66. TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression
    Caihong Wang, Shaosen Zhang, Boyuan Ma, Yan Fu, Yongzhang Luo · 2022 · Oncogene
  67. Cellular Origins and Lineage Plasticity in Cancer
    Jason Robert Pitarresi, Ben Z. Stanger · 2023 · Cold Spring Harbor Perspectives in Medicine
  68. ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells
    Ya-Ning Zhu, Jiong Li, Sang Li, Zhe Yang, Zhengkang Qiao, Xingshi Gu, Zhenhu He, Di Wu, Xiaoqian Ma, Shanhu Yao et al. · 2024 · Cell Communication and Signaling
  69. Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.
    Shogo Tajima, Michihiko Waki, Tomonori Tsuchiya, Shoji Hoshi · 2014 · PubMed Central
  70. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review
    Fares E.M. Ali, Islam Mohamed Ibrahim, Hanan S. Althagafy, Emad H. M. Hassanein · 2024 · International Immunopharmacology
  71. Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice
    Masashi Izumiya, Shingo Kato, Yoshitaka Hippo · 2021 · Cancers
  72. Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review
    Olga Kouroukli, Vasiliki Bravou, Konstantinos Giannitsas, Vassiliki Tzelepi · 2024 · Cancers
  73. FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy
    Teng Wei, Chenquan Zeng, Qineng Li, Zhiyuan Xiao, Leisheng Zhang, Qiangnu Zhang, Lili Ren · 2024 · Cancer Science
  74. Emerging biomarker in carcinogenesis. Focus on Nestin
    Katarzyna Nowogrodzka, Alina Jankowska‐Konsur · 2022 · Advances in Dermatology and Allergology
  75. BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer
    Wen Mi, Jianwei You, Liucheng Li, Lingzhi Zhu, Xinyi Xia, Li Yang, Fei Li, Yi Xu, Junfeng Bi, Pingyu Liu et al. · 2024 · Life Metabolism
  76. Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions
    Shangwei Sun, Yunwei Sun, Ling Lan, Siyuan Luan, Jin Rong Zhou, Jiehui Deng, Yong Yuan, Zhong Wu · 2025 · MedComm
  77. The molecular determinants of phenotypic plasticity in homeostasis and neoplasia
    Bradley Balk, David W. Goodrich · 2024 · Cancer Heterogeneity and Plasticity
  78. Other Primary Epithelial Neoplasms of the Liver
    Wai Szeto, Rifat Mannan · 2025 · Advances in Anatomic Pathology
  79. Update on Hepatobiliary Plasticity
    Minwook Kim, Fatima Rizvi, Donghun Shin, Valerie Gouon–Evans · 2023 · Seminars in Liver Disease
  80. Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer
    Verena Wagner, Laura Bousset, Mariana Ascensão-Ferreira, Bin Sun, Jose Efren Barragan Avila, Alexandre Kaizeler, Rita Martins-Silva, Mohammad Rahbari, Mirian Fernández-Vaquero, Scott Haston et al. · 2026 · Nature Communications
  81. Bladder cancer cells prevent cisplatin-induced oxidative stress by upregulating Nestin1 expression.
    Yifan Zhang, Yunlong Li · 2021 · PubMed Central
  82. Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis
    Lumi Huang, Lihui Chen, Yiming Wang, Fucheng Zhang, Ting Wang, Dairong Li, Chunmei Wang, Huiwen Ma · 2023 · The Turkish Journal of Gastroenterology
  83. The ascending aorta of male hypertensive bicuspid aortic valve patients preferentially associated with a cellular aneurysmal phenotype
    Alexandre Bergeron, Vanessa Hertig, Louis Robert Villeneuve, Vincent Chauvette, Ismaı̈l El-Hamamsy, Angelino Calderone · 2022 · Physiological Reports
  84. Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab
    Yichou Wei, Jiang-Yi Zhu, Jing Wu, Shan Yu, Wěi Li, Meng-Xuan Zhu, Tianshu Liu, Yuehong Cui, Qian Li · 2023 · Journal of Gastrointestinal Oncology
  85. Genes-first and phenotypes-first paths to treatment resistance in hematological malignancies
    Edoardo Tamellini, Cristina Frusteri, Isacco Ferrarini · 2025 · Cell Death and Disease
  86. p53: defender of lineage fidelity and foe of plasticity in cancer and regeneration
    Laura Donatella Attardi, Arati Rajeevan · 2026 · Trends in cancer
  87. Cell origin, biology, and pathophysiology of hepatocellular carcinoma
    Begum Dariya, Sujatha Peela, Ganji Purnachandra Nagaraju · 2022 · Elsevier eBooks
  88. 2-(4-Benzyloxy-3-methoxyphenyl)-5-(carbethoxyethylene)-7-methoxy-benzofuran, a Benzofuran Derivative, Suppresses Metastasis Effects in P53-Mutant Hepatocellular Carcinoma Cells
    Tsui‐Hwa Tseng, Yi-Chia Shao, Yean‐Jang Lee, Huei‐Jane Lee · 2023 · Biomedicines
  89. PPIs as therapeutic targets for anticancer drug discovery: the case study of MDM2 and BET bromodomain inhibitors
    Margarida Espadinha, Stuart J. Conway, Maria M. M. Santos · 2020 · Elsevier eBooks
  90. Integrated combinatorial functional genomics and spatial transcriptomics of tumors decodes genotype to phenotype relationships
    Marco Breinig, Artem Lomakin, Elyas Heidari, Michael A. Ritter, Gleb D. Rukhovich, Lio Böse, Luise Butthof, Lena Wendler-Link, Hendrik Wiethoff, Tanja Poth et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  91. The rise of RAS: how gradual oncogene activation shapes the OIS spectrum
    Haoran Zhu, Adelyne Sue Li Chan, Masashi Narita · 2025 · Genes & Development
  92. Ovarian Microcystic Stromal Tumor with Significant Nestin Expression: A Unique Case
    Bao Jun Wu, Chongming Wu, Dandan Li, Zhanmin Yang, Ying Liu, Haixia Zhang, Hong-Wu Xin, Yuqin Bai · 2024 · Internal Medicine
  93. Oncogenesis in cholangiocarcinoma
    Rares Ilie Orzan, Andrada Seicean · 2025 · Advances in clinical chemistry
  94. p53 and cellular plasticity
    Sarah E. Seton-Rogers · 2014 · Nature reviews. Cancer
  95. Nestin protein affects the maintenance of stem characteristics of colorectal cancer cells based on p53 dependent pathway
    Zhi‐Wang Li, Zuguang Wu, Han Yu, Yuping Liu, Weisheng Wu, En Li · 2022 · Journal of Gastrointestinal Oncology
  96. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas
    Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2023 · Pathology - Research and Practice
  97. Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathway
    Hyuk Moon, Hyunjung Park, S.-H. Lee, Soyun Lee, Mihyeon Jun, Jaehun Lee, Jiyeon Baek, Hyerin Park, Jieun Bang, Simon Weonsang Ro · 2025 · JHEP Reports
  98. Cancer Stem Cell Plasticity – A Deadly Deal
    P. T. Archana, Saxena Kritika, Reshma Murali, Mohit Kumar Jolly, Radhika Nair · 2019 · Preprints.org
  99. Be mindful of potential pitfalls when using the Cre-LoxP system in cancer research
    Piotr, Jaroslaw · 2023 · Oncoscience
  100. Epithelial Tumors of the Liver of Uncertain Lineage
    Arthur Zimmermann · 2016 · Springer eBooks